Bischoff S C
Division of Gastroenterology and Hepatology, Medical School of Hannover, Germany.
Baillieres Clin Gastroenterol. 1996 Sep;10(3):443-59. doi: 10.1016/s0950-3528(96)90052-4.
Despite the progress made in understanding the mechanisms of allergic disease, the pathophysiology and clinical significance of intestinal allergic reactions is largely unclear. The intestinal mucosa is pre-destined for allergic reactions against food proteins and other antigens, and a number of studies indicate that allergic reactions occur in the GI tract. However, only a few epidemiological data are available, and the mechanisms are poorly understood. Intestinal allergic reactions may be different to classical IgE-mediated reactions because patients with intestinal allergy often have negative skin tests and low levels of serum IgE. There is increasing evidence that, as with the findings in the skin and lung, mast cells and eosinophils play a central role in mediating intestinal allergic reactions. Furthermore, both types of cell are found to be activated in a number of other GI inflammatory diseases such as inflammatory bowel disease, celiac disease and eosinophilic gastroenteritis. However, the relationship between these pathologies and intestinal allergy is largely unclear. A major clinical problem is the lack of appropriate means for confirming the diagnosis of intestinal allergy. However, new test systems have been developed--such as the measurement of eosinophil mediators in stool samples or endoscopic provocation tests performed locally at the intestinal mucosa, which may improve the possibility of identifying afflicted patients on an objective basis. Since symptoms of intestinal allergic reactions are variable and non-specific, the diagnosis requires the use of multiple tests and the exclusion of other pathologies such as infectious disease or non-immunological intolerance reactions. The preferred therapeutic option is avoidance of the allergens of relevance; however, this approach can be realized only in some patients, whereas others require additional treatment, for example, with oral cromoglycate or corticosteroids. Although we do not yet know to what extent intestinal allergic reactions may be an aetiological factor in GI diseases, such reactions should be considered in the differential diagnosis of unclear intestinal inflammation and irritable bowel syndrome.
尽管在理解过敏性疾病机制方面取得了进展,但肠道过敏反应的病理生理学和临床意义在很大程度上仍不清楚。肠道黏膜注定会对食物蛋白和其他抗原产生过敏反应,多项研究表明胃肠道会发生过敏反应。然而,仅有少量流行病学数据,且其机制尚不清楚。肠道过敏反应可能与经典的IgE介导反应不同,因为肠道过敏患者的皮肤试验通常为阴性,血清IgE水平也较低。越来越多的证据表明,与皮肤和肺部的情况一样,肥大细胞和嗜酸性粒细胞在介导肠道过敏反应中起核心作用。此外,在其他一些胃肠道炎症性疾病如炎症性肠病、乳糜泻和嗜酸性粒细胞性胃肠炎中,发现这两种细胞均被激活。然而,这些疾病与肠道过敏之间的关系在很大程度上仍不清楚。一个主要的临床问题是缺乏确诊肠道过敏的合适方法。不过,已经开发出了新的检测系统,如测量粪便样本中的嗜酸性粒细胞介质或在肠道黏膜局部进行内镜激发试验,这可能会提高客观识别患病患者的可能性。由于肠道过敏反应的症状多变且不具特异性,诊断需要使用多种检测方法并排除其他疾病,如传染病或非免疫性不耐受反应。首选的治疗方法是避免接触相关过敏原;然而,这种方法仅在部分患者中可行,而其他患者则需要额外治疗,例如口服色甘酸或使用皮质类固醇。尽管我们尚不清楚肠道过敏反应在多大程度上可能是胃肠道疾病的病因,但在对不明原因的肠道炎症和肠易激综合征进行鉴别诊断时,应考虑这种反应。